Among a group of men who had a low serum and underwent coronary angiography Testosterone level, the use of testosterone treatment was associated with increased risk of death, heart attack, or ischemic stroke, based on a study in the November 6 issue of JAMA. The men either received testosterone
gel - the most common type of testosterone therapy - or a placebo. The results demonstrated that of the 12 Sexuality measurements in the questionnaire, http://tinyurl.com/zq3zb78
10 were significantly enhanced for guys in the testosterone group. In addition, it depends on how many other cycles of Testosterone treatment you have participated in. Sometimes, people's awareness of betterment and heightened wherewithal starts to dwindle or stay stagnant.
We're also requiring manufacturers of approved testosterone products to run a well-designed clinical trial to clearly address the question of whether an increased risk of stroke or heart attack exists among users of the products. We encourage health care professionals and patients to report side effects involving testosterone products to the FDA MedWatch program, using the information in the Contact FDA" box at the bottom of the page.
The normal ranges for blood testosterone are: Males 300-1,200 ng/dl, Female 30-95 ng/dl. This is definitely different from using testosterone as an antiageing treatment and the blend of HGH. We hear a lot in the news about weight lifters and sports using anabolic steroids to increase muscle mass, http://tinyurl.com/zq3zb78
but this is, in addition, distinct from the HGH and testosterone blend discussed in this article. Another hormone therapy, which is believed by some to create anti aging advantages is DHEA (dehydroepiandrosterone).
Earlier this year, the U.S. Food and Drug Administration required producers of all authorized testosterone products to add info on the labels to clarify the accepted uses of the drugs and include advice about potential increased risks of heart attacks and strokes in patients taking testosterone. But patients and doctors must weigh the benefits and risks of providing testosterone supplementation to patients based on the information supplied by the FDA and other research.